All news from Pulmonary Medicine

Blood Test Helps Identify Distinct Molecular Signatures In Children With Cystic Fibrosis

Researchers at Stanley Manne Children's Research Institute at Ann & Robert H. Lurie Children's Hospital of Chicago, and colleagues, used a blood test and microarray technology to identify distinct molecular signatures in children with cystic fibrosis. These patterns of gene expression could help predict disease severity and treatment response, and lead to therapies tailored to each patient's precise biology. Findings were published in  Physiological Genomics.

Lung Cancer: Governments across Europe Respond in Very Different Ways

Initial research of lung cancer from the study, which will run into early 2019 with in-depth country research and workshops, will be presented by the Economist Intelligence Unit at the European Cancer Forum in Brussels, which is hosted by MSD. The audience of policy-makers, academics, healthcare professionals, industry, and patient representatives, will provide the first sounding-board for the study findings, and help focus the next phase of research. The EIU will be looking to understand whether countries are advancing, innovating and seizing the opportunities to save lives.

Benefits of Immunotherapy in Lung Cancer, International Study

The strategy for triggering the patient's own immune system to attack cancer, immunotherapy, is proving useful for more and more tumor types, although to varying degrees. In lung cancer, immunotherapy had proven to extend survival rates for only some variants of the disease.

Now, an international clinical trial which also encompasses professionals has substantially increased the group of lung cancer patients who may benefit from immunotherapy.